Weinstein Robert
- SEC CIK
- 0001213709
No open-market purchases or sales filed in the past year.
Current role at each company
- XWEL XWELL, Inc.Directoras of Sep 2, 2026
- PMCB PharmaCyte Biotech, Inc.Directoras of Jul 17, 2026
- TAOX TAO Synergies Inc.Chief Financial Officeras of May 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Weinstein Robert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XWEL XWELL, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2021 (view filing) | Sep 20 | 32 daysLate | Weinstein RobertDirector | SSale | −63.0K | $1.43 | −$90.1K | −27.6%165.2K after | |
| Jan 21, 2022 (view filing) | Jan 19 | 2 days | Weinstein RobertDirector | SSale | −45.0K | $1.56 | −$70.2K | −27.2%120.2K after | |
| Apr 22, 2022 (view filing) | Apr 20 | 2 days | Weinstein RobertDirector | SSale | −45.0K | $1.06 | −$47.7K | −29.7%106.5K after | |
| May 30, 2023 (view filing)8:34 AM ET | May 26 | 4 days | Weinstein RobertDirector | PPurchase | +25.0K | $0.25 | +$6.25K | +23.5%131.5K after | |
| May 31, 2023 (view filing)8:32 AM ET | May 30 | 1 day | Weinstein RobertDirector | PPurchase | +25.0K | $0.247 | +$6.17K | +19.0%156.5K after |
TAOX TAO Synergies Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Weinstein RobertChief Financial Officer | SSaleCommon Stock, par value $0.0001 per share | −27.0K | $1.17 | −$31.6K | −44.9%33.2K after |